{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,1,22]],"date-time":"2024-01-22T02:29:50Z","timestamp":1705890590647},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2015,6,1]],"date-time":"2015-06-01T00:00:00Z","timestamp":1433116800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Sanofi K.K."}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diabetes Ther"],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.1007\/s13300-015-0111-5","type":"journal-article","created":{"date-parts":[[2015,6,4]],"date-time":"2015-06-04T02:46:03Z","timestamp":1433385963000},"page":"153-171","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Improved Treatment Satisfaction and Self-reported Health Status after Introduction of Basal-Supported Oral Therapy Using Insulin Glargine in Patients with Type 2 Diabetes: Sub-Analysis of ALOHA2 Study"],"prefix":"10.1007","volume":"6","author":[{"given":"Shoko","family":"Tsukube","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yukio","family":"Ikeda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Kadowaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masato","family":"Odawara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,6,4]]},"reference":[{"key":"111_CR1","unstructured":"Japan Diabetes Society. Chapter 3A: treatment objectives and control indicators. In: Japan Diabetes Society, editor. Treatment Guide for Diabetes 2014\u20132015. Tokyo: Bunkodo Co., Ltd.; 2014. p. 24\u20136 (in Japanese)."},{"key":"111_CR2","doi-asserted-by":"publisher","first-page":"140","DOI":"10.2337\/dc14-2441","volume":"38","author":"SE Inzucchi","year":"2015","unstructured":"Inzucchi SE, Bergenstal RM, Buse JB, et al. Management of hyperglycemia in Type 2 diabetes, 2015: a patient-centered approach: update to a position statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care. 2015;38:140\u20139.","journal-title":"Diabetes Care"},{"key":"111_CR3","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.2337\/diacare.25.7.1159","volume":"25","author":"SL Norris","year":"2002","unstructured":"Norris SL, Lau J, Smith SJ, Schmid CH, Engelgau MM. Self-management education for adults with type 2 diabetes: a meta-analysis of the effect on glycemic control. Diabetes Care. 2002;25:1159\u201371.","journal-title":"Diabetes Care"},{"key":"111_CR4","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1016\/S0149-2918(02)85131-1","volume":"24","author":"JC Cappelleri","year":"2002","unstructured":"Cappelleri JC, Cefalu WT, Rosenstock J, Kourides IA, Gerber RA. Treatment satisfaction in type 2 diabetes: a comparison between an inhaled insulin regimen and a subcutaneous insulin regimen. Clin Ther. 2002;24:552\u201364.","journal-title":"Clin Ther"},{"key":"111_CR5","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1002\/da.10140","volume":"19","author":"SS Colman","year":"2004","unstructured":"Colman SS, Brod M, Potter LP, Buesching DP, Rowland CR. Cross-sectional 7-year follow-up of anxiety in primary care patients. Depress Anxiety. 2004;19:105\u201311.","journal-title":"Depress Anxiety"},{"key":"111_CR6","doi-asserted-by":"crossref","unstructured":"Fisher EB, Thorpe CT, Devellis BM, Devellis RF. Healthy coping, negative emotions, and diabetes management: a systematic review and appraisal. Diabetes Educ 2007;33:1080\u2013103 (discussion 1104\u20136).","DOI":"10.1177\/0145721707309808"},{"key":"111_CR7","doi-asserted-by":"crossref","unstructured":"Riddle MC, Rosenstock J, Gerich J, and on behalf of the Insulin Glargine 4002 Study Investigators. The treat-to-target trial: randomized addition of glargine or human NPH insulin to oral therapy of type 2 diabetic patients. Diabetes Care 2003;26:3080\u20136.","DOI":"10.2337\/diacare.26.11.3080"},{"key":"111_CR8","doi-asserted-by":"publisher","first-page":"952","DOI":"10.7326\/0003-4819-138-12-200306170-00006","volume":"138","author":"A Fritsche","year":"2003","unstructured":"Fritsche A, Schweitzer MA, H\u00e4ring HU. 4001 Study Group. Glimepiride combined with morning insulin glargine, bedtime neutral protamine hagedorn insulin, or bedtime insulin glargine in patients with type 2 diabetes. A randomized, controlled trial. Ann Intern Med. 2003;138:952\u20139.","journal-title":"Ann Intern Med"},{"key":"111_CR9","doi-asserted-by":"publisher","first-page":"631","DOI":"10.2337\/diacare.24.4.631","volume":"24","author":"J Rosenstock","year":"2001","unstructured":"Rosenstock J, Schwartz SL, Clark CM Jr, Park GD, Donley DW, Edwards MB. Basal insulin therapy in type 2 diabetes: 28-week comparison of insulin glargine (HOE901) and NPH insulin. Diabetes Care. 2001;24:631\u20136.","journal-title":"Diabetes Care"},{"key":"111_CR10","doi-asserted-by":"publisher","first-page":"1743","DOI":"10.2165\/00003495-200363160-00007","volume":"63","author":"CJ Dunn","year":"2003","unstructured":"Dunn CJ, Plosker GL, Keating GM, McKeage K, Scott LJ. Insulin glargine: an updated review of its use in the management of diabetes mellitus. Drugs. 2003;63:1743\u201378.","journal-title":"Drugs"},{"key":"111_CR11","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.2337\/diacare.23.8.1130","volume":"23","author":"H Yki-J\u00e4rvinen","year":"2000","unstructured":"Yki-J\u00e4rvinen H, Dressler A, Ziemen M, HOE 901\/300s Study Group. Less nocturnal hypoglycemia and better post-dinner glucose control with bedtime insulin glargine compared with bedtime NPH insulin during insulin combination therapy in type 2 diabetes. HOE 901\/3002 Study Group. Diabetes Care. 2000;23:1130\u20136.","journal-title":"Diabetes Care"},{"key":"111_CR12","doi-asserted-by":"publisher","first-page":"273","DOI":"10.4236\/jdm.2014.44039","volume":"4","author":"M Kobayashi","year":"2014","unstructured":"Kobayashi M, Tsukube S, Ikeda Y, Shuto Y. Safety and efficacy of combination therapy with insulin glargine and oral hypoglycaemic agents including DPP-4 inhibitors in Japanese T2DM patients: ALOHA 2 study, a post-marketing surveillance for Lantus. J Diabetes Mellit. 2014;4:273\u201389.","journal-title":"J Diabetes Mellit."},{"key":"111_CR13","doi-asserted-by":"crossref","unstructured":"Secnik Boye K, Matza LS, et al. Patient-reported outcomes in a trial of exenatide and insulin glargine for the treatment of type 2 diabetes. Health Qual Life Outcomes 2006;4:80.","DOI":"10.1186\/1477-7525-4-80"},{"key":"111_CR14","doi-asserted-by":"publisher","first-page":"795","DOI":"10.2337\/dc06-1712","volume":"30","author":"AI Vinik","year":"2007","unstructured":"Vinik AI, Zhang Q. Adding insulin glargine versus rosiglitazone: health-related quality-of-life impact in type 2 diabetes. Diabetes Care. 2007;30:795\u2013800.","journal-title":"Diabetes Care"},{"key":"111_CR15","unstructured":"Bradley-Gibride J, Bradley C. Partially randomized preference trial design. In: Salkind Neil J, editor. Encyclopedia of research design. Vol. 2. Thousand Oaks: Sage Publications USA; 2010."},{"key":"111_CR16","doi-asserted-by":"publisher","first-page":"e41358","DOI":"10.1371\/journal.pone.0041358","volume":"7","author":"T Kadowaki","year":"2012","unstructured":"Kadowaki T, Ohtani T, Odawara M. Potential formula for the calculation of starting and incremental insulin glargine doses: ALOHA subanalysis. PLoS One. 2012;7:e41358.","journal-title":"PLoS One"},{"key":"111_CR17","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1089\/dia.2011.0220","volume":"14","author":"M Odawara","year":"2012","unstructured":"Odawara M, Ohtani T, Kadowaki T. Dosing of insulin glargine to achieve the treatment target in Japanese type 2 diabetes on a basal supported oral therapy regimen in real life: ALOHA study subanalysis. Diabetes Technol Ther. 2012;14:635\u201343.","journal-title":"Diabetes Technol Ther"},{"issue":"6","key":"111_CR18","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/1758-5996-6-20","volume":"15","author":"M Odawara","year":"2014","unstructured":"Odawara M, Kadowaki T, Naito Y. Incidence and predictors of hypoglycemia in Japanese patients with type 2 diabetes treated by insulin glargine and oral antidiabetic drugs in real-life: ALOHA post-marketing surveillance study sub-analysis. Diabetol Metab Syndr. 2014;15(6):20.","journal-title":"Diabetol Metab Syndr"},{"key":"111_CR19","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1007\/s13340-012-0087-6","volume":"4","author":"T Kadowaki","year":"2013","unstructured":"Kadowaki T, Ohtani T, Odawara M. Baseline predictive factors for glycemic control in Japanese type 2 diabetes patients treated with insulin glargine plus oral antidiabetic drugs: ALOHA study subanalysis. Diabetol Int. 2013;4:16\u201322.","journal-title":"Diabetol Int"},{"key":"111_CR20","doi-asserted-by":"crossref","unstructured":"Kashiwagi A, Kasuga M, Araki E, et al. Committee on the standardization of diabetes mellitus related laboratory testing of Japan Diabetes Society. International clinical harmonization of glycated hemoglobin in Japan: From Japan Diabetes Society to National Glycohemoglobin Standardization Program values. J Diabetes Investig. 2012;3:39\u201340.","DOI":"10.1111\/j.2040-1124.2012.00207.x"},{"key":"111_CR21","first-page":"809","volume":"192","author":"H Ishii","year":"2000","unstructured":"Ishii H, Bradley C, Riazi A, Barendse S, Yamamoto T. The Japanese Version of the Diabetes Treatment Satisfaction Questionnaire (DTSQ): translation and clinical evaluation. J Clin Exp Med. 2000;192:809\u201314 (in Japanese).","journal-title":"J Clin Exp Med"},{"key":"111_CR22","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1002\/hec.673","volume":"11","author":"A Tsuchiya","year":"2002","unstructured":"Tsuchiya A, Ikeda S, Ikegami N, et al. Estimating an EQ-5D population value set: the case of Japan. Health Econ. 2002;11:341\u201353.","journal-title":"Health Econ"},{"key":"111_CR23","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1111\/j.1464-5491.1990.tb01421.x","volume":"7","author":"C Bradley","year":"1990","unstructured":"Bradley C, Lewis KS. Measures of psychological well-being and treatment satisfaction developed from the responses of people with tablet-treated diabetes. Diabet Med. 1990;7:445\u201351.","journal-title":"Diabet Med"},{"key":"111_CR24","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/1477-7525-5-57","volume":"5","author":"C Bradley","year":"2007","unstructured":"Bradley C, Plowright R, Stewart J, Valentine J, Witthaus E. The Diabetes Treatment Satisfaction Questionnaire change version (DTSQc) evaluated in insulin glargine trials shows greater responsiveness to improvements than the original DTSQ. Health Qual Life Outcomes. 2007;5:57.","journal-title":"Health Qual Life Outcomes"},{"key":"111_CR25","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/0168-8510(90)90421-9","volume":"16","author":"EuroQol Group","year":"1990","unstructured":"EuroQol Group. EuroQol\u2014a new facility for the measurement of health-related quality of life. Health Policy. 1990;16:199\u2013208.","journal-title":"Health Policy"},{"key":"111_CR26","doi-asserted-by":"publisher","first-page":"193","DOI":"10.2337\/dc08-9025","volume":"32","author":"DM Nathan","year":"2009","unstructured":"Nathan DM, Buse JB, Davidson MB, et al. European Association for Study of Diabetes. Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care. 2009;32:193\u2013203.","journal-title":"Diabetes Care"},{"key":"111_CR27","doi-asserted-by":"publisher","first-page":"2543","DOI":"10.2337\/diacare.28.10.2543","volume":"28","author":"WH Polonsky","year":"2005","unstructured":"Polonsky WH, Fisher L, Guzman S, Villa-Caballero L, Edelman SV. Psychological insulin resistance in patients with type 2 diabetes: the scope of the problem. Diabetes Care. 2005;28:2543\u20135.","journal-title":"Diabetes Care"},{"key":"111_CR28","doi-asserted-by":"publisher","first-page":"9S","DOI":"10.1177\/0145721705285638","volume":"32","author":"J Meece","year":"2006","unstructured":"Meece J. Dispelling myths and removing barriers about insulin in type 2 diabetes. Diabetes Educ. 2006;32:9S\u201318S.","journal-title":"Diabetes Educ"},{"key":"111_CR29","doi-asserted-by":"publisher","first-page":"530","DOI":"10.2337\/diacare.22.3.530","volume":"22","author":"C Bradley","year":"1999","unstructured":"Bradley C. Diabetes treatment satisfaction questionnaire. Change version for use alongside status version provides appropriate solution where ceiling effects occur. Diabetes Care. 1999;22:530\u20132.","journal-title":"Diabetes Care"},{"key":"111_CR30","doi-asserted-by":"publisher","first-page":"143","DOI":"10.4158\/EP14079.OR","volume":"21","author":"SK Garg","year":"2015","unstructured":"Garg SK, Admane K, Freemantle N, et al. Patient-led versus physician-led titration of insulin glargine in uncontrolled patients with type 2 diabetes: a randomized multinational-ATLAS Study. Endocr Pract. 2015;21:143\u201357.","journal-title":"Endocr Pract"},{"key":"111_CR31","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1007\/s11136-011-0051-0","volume":"21","author":"TR Hajos","year":"2012","unstructured":"Hajos TR, Pouwer F, de Grooth R, et al. The longitudinal association between glycaemic control and health-related quality of life following insulin therapy optimisation in type 2 diabetes patients. A prospective observational study in secondary care. Qual Life Res. 2012;21:1359\u201365.","journal-title":"Qual Life Res"},{"key":"111_CR32","unstructured":"Marra G, DIAB. & TE.S Project Study Group. The DIAB. & TE.S Project: how patients perceive diabetes and diabetes therapy. Acta Biomed 2004;75:164\u201370."},{"key":"111_CR33","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1111\/j.1365-2702.2007.01772.x","volume":"16","author":"K Kelley","year":"2007","unstructured":"Kelley K, Dempsey C. An evaluation of an insulin transfer programme delivered in a group setting. J Clin Nurs. 2007;16:152\u20138.","journal-title":"J Clin Nurs"},{"key":"111_CR34","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1111\/j.1742-1241.2006.01190.x","volume":"61","author":"AA Tahrani","year":"2007","unstructured":"Tahrani AA, Digwood S, Lee C, Moulilk P. Evaluation of glargine group-start sessions in patients with type 2 diabetes as a strategy to deliver the service. Int J Clin Pract. 2007;61:329\u201335.","journal-title":"Int J Clin Pract"},{"key":"111_CR35","doi-asserted-by":"crossref","unstructured":"UK Prospective Diabetes Study Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet 1998;352:837\u201353 (Erratum in: Lancet 1999;354:602).","DOI":"10.1016\/S0140-6736(98)07019-6"},{"key":"111_CR36","doi-asserted-by":"publisher","first-page":"60","DOI":"10.2337\/diaclin.27.2.60","volume":"27","author":"K Niswender","year":"2009","unstructured":"Niswender K. Early and aggressive initiation of insulin therapy for type 2 diabetes: what is the evidence? Clin Diabetes. 2009;27:60\u20138.","journal-title":"Clin Diabetes"},{"key":"111_CR37","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.2337\/diacare.24.6.1069","volume":"24","author":"RJ Anderson","year":"2001","unstructured":"Anderson RJ, Freedland KE, Clouse RE, Lustman PJ. The prevalence of comorbid depression in adults with diabetes: a meta-analysis. Diabetes Care. 2001;24:1069\u201378.","journal-title":"Diabetes Care"},{"key":"111_CR38","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.2337\/diacare.22.7.1125","volume":"22","author":"UK Prospective Diabetes Study Group","year":"1999","unstructured":"UK Prospective Diabetes Study Group. Quality of life in type 2 diabetic patients is affected by complications but not by intensive policies to improve blood glucose or blood pressure control (UKPDS 37). UK Prospective Diabetes Study Group. Diabetes Care. 1999;22:1125\u201336.","journal-title":"Diabetes Care"},{"key":"111_CR39","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1007\/s00125-006-0249-9","volume":"49","author":"DJ Wexler","year":"2006","unstructured":"Wexler DJ, Grant RW, Wittenberg E, et al. Correlates of health-related quality of life in type 2 diabetes. Diabetologia. 2006;49:489\u201397.","journal-title":"Diabetologia"},{"key":"111_CR40","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1080\/02813430510015296","volume":"23","author":"PE W\u00e4ndell","year":"2005","unstructured":"W\u00e4ndell PE. Quality of life of patients with diabetes mellitus. An overview of research in primary health care in the Nordic countries. Scand J Prim Health Care. 2005;23:68\u201374.","journal-title":"Scand J Prim Health Care"},{"key":"111_CR41","doi-asserted-by":"publisher","first-page":"112","DOI":"10.2174\/157339909788166828","volume":"5","author":"MT Schram","year":"2009","unstructured":"Schram MT, Baan CA, Pouwer F. Depression and quality of life in patients with diabetes: a systematic review from the European depression in diabetes (EDID) research consortium. Curr Diabetes Rev. 2009;5:112\u20139.","journal-title":"Curr Diabetes Rev"},{"key":"111_CR42","doi-asserted-by":"publisher","first-page":"914","DOI":"10.2337\/diacare.27.4.914","volume":"27","author":"W Katon","year":"2004","unstructured":"Katon W, von Korff M, Ciechanowski P, et al. Behavioral and clinical factors associated with depression among individuals with diabetes. Diabetes Care. 2004;27:914\u201320.","journal-title":"Diabetes Care"},{"key":"111_CR43","doi-asserted-by":"publisher","first-page":"3278","DOI":"10.1001\/archinte.160.21.3278","volume":"160","author":"PS Ciechanowski","year":"2000","unstructured":"Ciechanowski PS, Katon WJ, Russo JE. Depression and diabetes: impact of depressive symptoms on adherence, function, and costs. Arch Intern Med. 2000;160:3278\u201385.","journal-title":"Arch Intern Med"},{"key":"111_CR44","doi-asserted-by":"publisher","first-page":"2154","DOI":"10.2337\/diacare.27.9.2154","volume":"27","author":"EH Lin","year":"2004","unstructured":"Lin EH, Katon W, von Korff M, et al. Relationship of depression and diabetes self-care, medication adherence, and preventive care. Diabetes Care. 2004;27:2154\u201360.","journal-title":"Diabetes Care"},{"key":"111_CR45","doi-asserted-by":"publisher","first-page":"264","DOI":"10.2337\/dc09-1068","volume":"33","author":"EH Lin","year":"2010","unstructured":"Lin EH, Rutter CM, Katon W, et al. Depression and advanced complications of diabetes: a prospective cohort study. Diabetes Care. 2010;33:264\u20139.","journal-title":"Diabetes Care"},{"key":"111_CR46","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.4236\/health.2013.56140","volume":"5","author":"B Mulhern","year":"2013","unstructured":"Mulhern B, Meadows K. Investigating the minimally important difference of the Diabetes Health Profile (DHP-18) and the EQ-5D and SF-6D in a UK diabetes mellitus population. Health. 2013;5:1045\u201354.","journal-title":"Health"}],"container-title":["Diabetes Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13300-015-0111-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13300-015-0111-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13300-015-0111-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13300-015-0111-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,26]],"date-time":"2019-08-26T02:59:44Z","timestamp":1566788384000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s13300-015-0111-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6]]},"references-count":46,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,6]]}},"alternative-id":["111"],"URL":"https:\/\/doi.org\/10.1007\/s13300-015-0111-5","relation":{},"ISSN":["1869-6953","1869-6961"],"issn-type":[{"value":"1869-6953","type":"print"},{"value":"1869-6961","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,6]]},"assertion":[{"value":"20 April 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 June 2015","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}